Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Aulos Bioscience, Inc.
Aulos Bioscience, Inc.
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
TILT Biotherapeutics Ltd.
ImmunityBio, Inc.
ImmunityBio, Inc.
ImmunityBio, Inc.
4SC AG
EMD Serono
Fate Therapeutics
Kartos Therapeutics, Inc.
4SC AG
Merck KGaA, Darmstadt, Germany